Giandomenico Roviello

Giandomenico Roviello

Università degli Studi di Firenze

H-index: 34

Europe-Italy

About Giandomenico Roviello

Giandomenico Roviello, With an exceptional h-index of 34 and a recent h-index of 32 (since 2020), a distinguished researcher at Università degli Studi di Firenze, specializes in the field of oncology.

His recent articles reflect a diverse array of research interests and contributions to the field:

A case report of a lung cancer patient with two uncommon EGFR mutations and a review of the literature: two sides of the same coin

Real-world outcome of patients with advanced renal cell carcinoma and intermediate-or poor-risk international metastatic renal cell carcinoma database consortium criteria …

Pembrolizumab-axitinib versus nivolumab-cabozantinib as first-line therapy in patients with metastatic renal cell carcinoma: a retrospective real-world comparison (ARON-1)

Targeting z-Crystallin by aspirin restores the sensitivity to cisplatin in resistant A2780 ovarian cancer cells

Clinical Outcomes and Prognostic Factors in Patients With Penile Carcinoma: A Sub-Analysis From Meet-URO 23 (I-RARE) Registry Study

Impact of Metastatic Site in Favorable-Risk Renal Cell Carcinoma Receiving Sunitinib or Pazopanib

Perineural invasion score system and clinical outcomes in resected pancreatic cancer patients

Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study

Giandomenico Roviello Information

University

Position

___

Citations(all)

4596

Citations(since 2020)

3767

Cited By

2047

hIndex(all)

34

hIndex(since 2020)

32

i10Index(all)

112

i10Index(since 2020)

95

Email

University Profile Page

Università degli Studi di Firenze

Google Scholar

View Google Scholar Profile

Giandomenico Roviello Skills & Research Interests

oncology

Top articles of Giandomenico Roviello

Title

Journal

Author(s)

Publication Date

A case report of a lung cancer patient with two uncommon EGFR mutations and a review of the literature: two sides of the same coin

Anti-Cancer Drugs

Federica Cosso

Giandomenico Roviello

Martina Catalano

Cristina Botteri

Camilla Eva Comin

...

2024/1/1

Real-world outcome of patients with advanced renal cell carcinoma and intermediate-or poor-risk international metastatic renal cell carcinoma database consortium criteria …

European Urology Oncology

Matteo Santoni

Sebastiano Buti

Zin W Myint

Marco Maruzzo

Roberto Iacovelli

...

2024/2/1

Pembrolizumab-axitinib versus nivolumab-cabozantinib as first-line therapy in patients with metastatic renal cell carcinoma: a retrospective real-world comparison (ARON-1)

Matteo Santoni

Giandomenico Roviello

Enrique Grande

Ugo Giorgi

Ondrej Fiala

...

2024/3/21

Targeting z-Crystallin by aspirin restores the sensitivity to cisplatin in resistant A2780 ovarian cancer cells

Matteo Lulli

Giandomenico Roviello

Martina Catalano

Astrid Parenti

Alice Molli

...

2024/1/25

Clinical Outcomes and Prognostic Factors in Patients With Penile Carcinoma: A Sub-Analysis From Meet-URO 23 (I-RARE) Registry Study

BMC cancer

Ho-Young Yhim

Hye Jin Kang

Yoon Hee Choi

Seok Jin Kim

Won Seog Kim

...

2010/12

Impact of Metastatic Site in Favorable-Risk Renal Cell Carcinoma Receiving Sunitinib or Pazopanib

Clinical Genitourinary Cancer

Martina Catalano

Ugo De Giorgi

Davide Bimbatti

Sebastiano Buti

Giuseppe Procopio

...

2024/1/14

Perineural invasion score system and clinical outcomes in resected pancreatic cancer patients

Pancreatology

Filippo Nozzoli

Martina Catalano

Luca Messerini

Fabio Cianchi

Romina Nassini

...

2024/3/15

Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study

Cancer Immunology, Immunotherapy

Francesco Massari

Matteo Santoni

Hideki Takeshita

Yohei Okada

Jose Carlos Tapia

...

2024/6

Time to strategy failure and treatment beyond progression in pretreated metastatic renal cell carcinoma patients receiving nivolumab: post-hoc analysis of the Meet-URO 15 study

Frontiers in Oncology

Veronica Murianni

Alessio Signori

Sebastiano Buti

Sara Elena Rebuzzi

Davide Bimbatti

...

2024

Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis

Brigida Anna Maiorano

Massimo Di Maio

Linda Cerbone

Evaristo Maiello

Giuseppe Procopio

...

2024/3/4

Real World Analysis of Peritoneal Metastasis From Renal Cell Carcinoma. Meet-Uro27

Marco Stellato

Sebastiano Buti

Marco Maruzzo

Giuseppe Fotia

Mariella Sorarù

...

2023/2/20

Platinum-based chemotherapy in metastatic prostate cancer: what possibilities?

JCO precision oncology

Jose Mauricio Mota

Ethan Barnett

Jones T Nauseef

Bastien Nguyen

Konrad H Stopsack

...

2020/4

The Conundrum of Cancer-Associated Thrombosis: Lesson Learned from Two Intriguing Cases and Literature Review

Simona Laurino

Sabino Russi

Ludmila Carmen Omer

Alberto D’Angelo

Giovanni Bozza

...

2024/2/28

Assessing the effectiveness and safety of lenvatinib and everolimus in advanced renal cell carcinoma: insights from the RELIEVE study’s analysis of heavily pretreated patients

Therapeutic Advances in Urology

Sebastiano Buti

Alessandro Olivari

Cristina Masini

Davide Bimbatti

Donata Sartori

...

2024/4

Minerva Urology and Nephrology 2023 August; 75 (4): 460-70

Minerva

Clara CERRATO

Margaret F MEAGHER

Riccardo AUTORINO

Giuseppe SIMONE

Bo YANG

...

2023/8

Gender and cystectomy for bladder cancer: A high-volume tertiary urologic care center experience

European Journal of Surgical Oncology

A Mariotti

P Spatafora

F Sessa

C Saieva

IC Galli

...

2023/10/1

Neoadjuvant versus adjuvant chemotherapy in muscle-invasive bladder cancer: The RealBLADDER study. Results on behalf of the GOIRC

European Urology Open Science

E Gambale

R GIORGIONE

IA VASCOTTO

I DE GENNARO AQUINO

F SCOLARI

...

2023/11/1

Immune checkpoint inhibitors in non-conventional histologies of renal-cell carcinoma

Melissa Bersanelli

Sara Elena Rebuzzi

Giandomenico Roviello

Martina Catalano

Matteo Brunelli

...

2023/1/2

Liquid Biopsy and Non-small-cell Lung Cancer: Expecting More Fluid Management of Patients

Current Pharmaceutical Biotechnology

Sara Fancelli

Giandomenico Roviello

Francesca Castiglione

Enrico Caliman

Mazzoni Francesca

...

2023/3/1

Clinical nutrition in surgical oncology: Young AIOM-AIRO-SICO multidisciplinary national survey on behalf of NutriOnc research group

Frontiers in Nutrition

Luigi Marano

Federica Marmorino

Isacco Desideri

Ludovico Carbone

Alessandro Rizzo

...

2023/4/14

See List of Professors in Giandomenico Roviello University(Università degli Studi di Firenze)

Co-Authors

H-index: 205
Adrian L Harris

Adrian L Harris

University of Oxford

H-index: 45
Roberta Alfieri

Roberta Alfieri

Università degli Studi di Parma

H-index: 28
Karol Polom

Karol Polom

Università degli Studi di Siena

H-index: 24
Giorgio Mustacchi

Giorgio Mustacchi

Università degli Studi di Trieste

H-index: 24
Raheleh Roudi

Raheleh Roudi

University of Minnesota-Twin Cities

academic-engine